Hypothalamic releasing factors and Parkinson disease.
D000978:Antiparkinson Agents / Q000008:administration & dosage; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005998:Glycine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007930:Leucine / Q000008:administration & dosage / Q000627:therapeutic use; D009074:Melanocyte-Stimulating Hormones; D009842:Oligopeptides / Q000008:administration & dosage / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D010906:Pituitary Hormone-Releasing Hormones / Q000037:antagonists & inhibitors*; D011392:Proline / Q000008:administration & dosage / Q000627:therapeutic use; D013973:Thyrotropin-Releasing Hormone / Q000627:therapeutic use*
D000978:Antiparkinson Agents; D009842:Oligopeptides; D010906:Pituitary Hormone-Releasing Hormones; D013973:Thyrotropin-Releasing Hormone; D004295:Dihydroxyphenylalanine; D009074:Melanocyte-Stimulating Hormones; D011392:Proline; D007930:Leucine; D005998:Glycine